Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapySelective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 geneCombination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and diseaseRegulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentIGF binding proteins in cancer: mechanistic and clinical insightsVitamin D: a growing perspectiveInteractions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancerKnockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsElevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles.Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression.Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic womenThe anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy.Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factorToward a core nutraceutical program for cancer management.Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression.Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.The vitamin D receptor as a therapeutic target.Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.Hepatic stem cells and transforming growth factor β in hepatocellular carcinomaTherapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.Interaction of vitamin D with membrane-based signaling pathwaysCurcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression.Vitamin D in cancer chemoprevention.Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1alpha,25-dihydroxyvitamin D3.The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cellsIs there any correlation between vitamin D insufficiency and diabetic retinopathy?The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis.Yin yang 1 and adipogenic gene network expression in longissimus muscle of beef cattle in response to nutritional management.Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects.A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.IGFBP-3 Interacts with the Vitamin D Receptor in Insulin Signaling Associated with Obesity in Visceral Adipose Tissue.
P2860
Q22299231-C45CC277-5D21-4CB0-A179-C43AF42BBD01Q24302292-14A48251-E1C3-4C36-A821-7A61FC036A2CQ24633922-B5CBACA3-3C38-4F3F-88B1-454FDA8A5C2CQ25256835-39A0A5CC-83B7-49FA-8BBE-1472F694F460Q26798408-FA36D34F-D446-4592-ADFF-1213012CB5C4Q28237971-4429BAFC-4DFD-4CC7-8E31-2B189CE8097FQ28284634-DD616454-4036-4AF7-A94D-FC2B570D7EA6Q28740805-A3AD67C4-BD29-4D3A-A632-8E60E6424BE8Q33563699-AF1EF3ED-7EF7-424E-AB74-53DEB8159899Q34094960-A40A18C8-5AE3-4DF7-972D-AA8DB2FAA612Q34358801-8AB44DE6-D624-45E0-BC63-3E69E66C04A0Q34526408-DBB36E04-27CA-480B-B711-CC63A8D7C0A6Q34723871-A87C6134-F2FE-41D0-8DE0-4CE8659AB50CQ34812753-D9F37315-D9A9-40B8-BAED-EC80A6D394B7Q35188826-6E89A13B-34E3-4A66-A08D-A8EC6346583EQ35620895-D5BDB1A5-D4B8-4B6A-939C-8BAE29361F3BQ36297109-4C69B19F-88C3-4E92-A5F2-89AC19B918E6Q36344273-5218AF98-A75E-48BE-96D1-6CA6D2E3D707Q36473648-023DC436-9084-4F13-9D34-BAD85F8AF325Q36498092-F0AEC961-F3D0-4BF0-823C-AACA7CBB1FBFQ36587617-277860DE-293D-4822-8081-DE466CC84FC9Q36596696-1212B45F-2E7D-4440-B99B-A319E542050DQ36955081-45882A8F-2C55-4DB5-AAF2-7B1D0FCA9C19Q37099380-2729C3B7-77D3-4C6E-BB03-65C0B4AA66B6Q37481349-BF7DE99F-0711-4B69-B655-49AC878FDFD0Q38193801-A4C6AA94-0B2F-44E2-B22F-70AC84CEEDB4Q38346733-B07AF0A9-8395-4693-9832-8C1D23D99B64Q38412880-64ADBA48-E3FE-40FB-A377-FA1921A158C8Q39653673-23F5B433-550C-49E1-AB57-705B71F280C1Q39705022-1C1C4301-40A3-4043-AB98-2A1533094BD2Q40050054-03221432-1493-42B5-9AA0-D0D1E1A5DFF9Q40216278-474032D6-034F-4DA7-BEA1-16C9F8C2180FQ40643683-989DFF44-BE88-4D5D-85AE-8C725FC1E5DBQ40700106-31775598-FB84-4BFC-B404-0463E8E77757Q43116169-5B7438AD-B8E9-4C1C-A08B-219FC9D76D78Q43892885-509447A2-831C-4444-BD0A-167202BF2532Q45305651-1ABCC9E8-459A-436F-BA12-1F70E1223AF9Q47109494-323A5767-EAD1-45FA-B8BC-A7378775EC23
P2860
Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3
@nl
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@ast
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@en
type
label
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3
@nl
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@ast
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@en
prefLabel
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3
@nl
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@ast
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3.
@en
P2093
P2860
P356
P1476
Regulation of multiple insulin ...... 1alpha,25-dihydroxyvitamin D3
@en
P2093
Katri Saavalainen
Marjo Malinen
Merja Matilainen
P2860
P304
P356
10.1093/NAR/GKI872
P407
P577
2005-09-26T00:00:00Z